Search the Newsreel

Oncoclinicas (ONCO3) vê prejuízo saltar 234%, para R$ 475 milhões; empresa tem ajustes contábeis 'significativos'

Merit Medical Systems Eyes New Long-Range Plan as Growth, Margins Gain Momentum

Merit Medical Systems (MMSI) is developing a new long-range plan, building on recent revenue and margin growth under new CEO Martha. The company has reorganized its reporting structure into Foundational and Therapeutic product categories and is focusing on disciplined M&A to deepen existing market …

90,788 Shares in Becton, Dickinson and Company $BDX Acquired by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. has acquired 90,788 shares of Becton, Dickinson and Company (NYSE:BDX) valued at approximately $13.7 million during the second quarter. The medical instruments supplier reported strong quarterly earnings, beating analyst estimates, and maintained its fiscal 2026 EPS guidance. While institutional investors …

Fischer Medical Ventures consolidated net profit declines 22.02% in the June 2026 quarter

555,953 Shares in Becton, Dickinson and Company $BDX Bought by Everett Harris & Co. CA

Everett Harris & Co. CA has purchased 555,953 shares of Becton, Dickinson and Company (NYSE:BDX) in the second quarter, making it their 21st largest holding valued at approximately $84.13 million. Other institutional investors have also adjusted their positions, and 86.97% of the stock is …

Bryn Mawr Trust Advisors LLC Purchases Shares of 46,332 Becton, Dickinson and Company $BDX

Bryn Mawr Trust Advisors LLC acquired 46,332 shares of Becton, Dickinson and Company (BDX) in the second quarter, valuing their new stake at approximately $7.0 million. This comes as institutional investors collectively own 86.97% of BDX, which recently exceeded quarterly earnings expectations with $3.23 …

Merit Medical Systems, Inc. $MMSI Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP significantly increased its stake in Merit Medical Systems (MMSI) by 200.3% in the first quarter, now owning 17,612 shares valued at approximately $1.21 million. This comes as institutional investors collectively hold 99.66% of the stock, and analysts maintain a "Moderate …

Is Nordic American Tankers (NAT) Already Overvalued After A 391% Return?

Nordic American Tankers (NAT) has shown significant returns of 391% over the last five years, but current valuations suggest the stock is overvalued. Both the Dividend Discount Model (DDM) and the P/E ratio indicate that NAT is trading at a premium, with the DDM …

Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold"

Wall Street Zen has upgraded Vivani Medical (NASDAQ:VANI) from a "sell" to a "hold" rating, contributing to a consensus "Hold" rating with an average price target of $3.75. Analyst opinions are varied, with Lake Street Capital initiating coverage with a "buy" rating and a …

SBC Medical Group (NASDAQ:SBC) Stock Rating Upgraded by Wall Street Zen

Parabilis Medicines(PBLS) Stock Options Chain | Quotes & News

The article provides information related to Parabilis Medicines (PBLS) stock options chain, including quotes and news. The content itself is not available in the provided input.

Prime Medicine, Inc. Stock 12‑Month Price Target Cut to $6.92, Implies 124% Upside

The average 12-month price target for Prime Medicine, Inc. (PRME) stock has been lowered from $7.12 to $6.92 by 9 analysts, yet this new target still suggests a significant 124% potential upside from its August 14th closing price. The consensus rating for PRME remains …

Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal

Vivani Medical (NASDAQ: VANI) announced full enrollment in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also signed a non-exclusive agreement with Novo Nordisk for evaluating NPM-139 and its NanoPortal technology. Additionally, Vivani …

Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 804 Shares

Disc Medicine (NASDAQ:IRON) COO Jonathan Yen-Wen Yu recently sold 804 shares of the company's stock for $66,442.56, reducing his total holdings by 1.46%. This sale is part of a series of insider transactions since mid-June. Despite these sales, the company exceeded its recent quarterly …

Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ

SBC Medical Group Holdings (SBC) Stock Reprices As Margins Power Profit Surge

Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com

Disc Medicine's COO, Jonathan Yu, sold 804 shares of the company's common stock for a total of $66,444 at an average price of $82.6425. This transaction was part of a pre-arranged trading plan, and it occurred as the stock had seen a 41% return …

Disc Medicine (NASDAQ: IRON) COO trades 804 shares via 10b5-1 plan

Disc Medicine's COO, Yu Jonathan Yen-Wen, exercised stock options for 804 shares at $13.50 each and simultaneously sold these 804 shares at a weighted average price of $82.6425. These transactions, which generated an approximate pre-tax spread of $56,000, were conducted under a pre-arranged Rule …

Is BeOne Medicines AG (ONC) Deal With Revolution Medicines (RVMD) a Win-Win for Both Companies?

Two oncology powerhouses, BeOne Medicines AG (NASDAQ:ONC) and Revolution Medicines, Inc. (NASDAQ:RVMD), announced a major multi-part clinical collaboration and regional licensing deal. Under the August 10 agreement, the companies will combine select clinical-stage assets from BeOne with Revolution's four clinical-stage RAS(ON) inhibitors to evaluate …

Journey Medical (DERM) Stock Eyes Break Even As Emrosi Gains Traction

Perceptive Advisors (NVNO) reports 3.5% beneficial stake via 24,605 warrants

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have reported a beneficial ownership of 3.5% in enVVeno Medical Corporation (NVNO) through 24,605 exercisable warrants. This stake represents 24,605 shares of common stock, based on 682,722 shares outstanding as of July …

Modular Medical, Inc. Q1 FY2027: Net loss $(6.49M), EPS $(1.19) — 10-Q Summary

Modular Medical, Inc. (MODD) reported a net loss of $(6.49M) for Q1 FY2027, an improvement from the prior year, with diluted loss per share at $(1.19). The company's cash and cash equivalents significantly decreased, leading to a flagged going-concern risk due to liquidity issues. …

Adagio Medical Receives Nasdaq Listing Deficiency Notice

Insider Selling: Becton, Dickinson and Company (NYSE:BDX) CEO Sells $768,120.00 in Stock

Becton, Dickinson and Company's CEO, Thomas Polen, Jr., sold 4,152 shares of BDX stock worth $768,120 under a pre-arranged Rule 10b5-1 trading plan, reducing his direct ownership by 3.63%. This sale occurred as the company's shares rose 0.7% to $183.16, near its 52-week high, …

ENvue Medical, Inc. SEC Filing (Aug 14, 2026)

ENvue Medical, Inc. has filed a Form 12b-25 Notification of Late Filing for its Quarterly Report on Form 10-Q for the period ended June 30, 2026. The company stated that additional time is needed to prepare, compile, and analyze supporting documentation to complete its …

Fuller & Thaler boosts disclosure of 5.19% ICU Medical (ICUI) ownership stake

Fuller & Thaler Asset Management, Inc. has filed an amended Schedule 13G, disclosing a 5.19% beneficial ownership stake in ICU Medical (ICUI). The firm holds 1,298,126.96 shares, with sole voting power over 1,276,819.96 shares and sole dispositive power over all 1,298,126.96 shares. The filing, …

Adagio Medical Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Adagio Medical Holdings (ADGM) received a Nasdaq deficiency notice on August 13, 2026, for failing to meet the Listing Rule 5550(b)(1) requirement of at least $2.5 million in stockholders' equity, as their June 30, 2026 Form 10-Q reported equity of $(415,000). The notice does …

Becton Dickinson (BDX) CEO exercises 43,278 SARs and disposes shares under 10b5-1 plan

Becton Dickinson & Co. Chairman, CEO, and President Thomas E. Polen Jr. exercised 43,278 Stock Appreciation Rights (SARs) on August 13, 2026, receiving common shares. Subsequently, he returned 39,126 shares to the issuer and sold 4,152 shares at $185.00 each. These transactions were conducted …

IceCure Medical (ICCM) expands 2024 employee share incentive reserve

IceCure Medical Ltd. has increased the ordinary shares reserved for its 2024 Employee Equity Incentive Plan by 2,500,000, bringing the new total to 2,612,667 ordinary shares. This expansion, approved by the board on August 11, 2026, provides additional capacity for future equity awards to …

Mobia Medical (MOBI) gets 11.1% ownership filing from Green Park & Golf group

Green Park & Golf Ventures II, LLC and affiliated entities have reported a beneficial ownership of 11.1% in Mobia Medical, Inc. (MOBI), totaling 3,684,409 shares. This stake is held across numerous LLCs, with managers Clay M. Heighten, MD, Carl D. Soderstrom, and Gilbert G. …

Profound Medical CFO Steps Down; Controller Takes Interim Role

Profound Medical (NASDAQ: PROF; TSX: PRN) has announced a management change, with Matthew Sobczyk, formerly Corporate Controller, promoted to Interim Chief Financial Officer. He succeeds Rashed Dewan, who has stepped down but will remain on a short-term consulting contract to ensure a smooth transition. …

Baker Bros. Advisors (RVMD) discloses 11.4M-share position in Revolution Medicines

Baker Bros. Advisors LP and related entities have reported a passive ownership stake of 5.3% in Revolution Medicines, Inc. This translates to beneficial ownership of 11,443,357 shares of common stock, held through investment funds Baker Brothers Life Sciences, L.P. and 667, L.P. The filing …

Parabilis Medicines (PBLS): ARCH Venture group discloses 6.4M-share, 5.3% ownership

ARCH Venture Fund XII and related entities have disclosed a 5.3% beneficial ownership stake in Parabilis Medicines (PBLS), amounting to 6,412,780 shares of common stock. This Schedule 13G filing indicates a passive investment, with ARCH Venture Partners XII, L.P., ARCH Venture Partners XII, LLC, …

Kestra Medical Technologies (KMTS) Nears Its Fair Value, Is The Stock Already Fully Valued?

Kestra Medical Technologies (KMTS) has seen recent positive share price momentum, with its stock closing at US$27.74. While a common narrative suggests the stock is undervalued with a fair value of $28 based on ambitious growth assumptions, other metrics like the P/S ratio indicate …

Praxis Precision Medicines (PRAX): Orbis, Allan Gray disclose 5.5% ownership stake

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd have jointly disclosed a 5.5% ownership stake in Praxis Precision Medicines (PRAX), amounting to 1,529,788 shares of common stock as of June 30, 2026. Orbis holds the majority with 1,526,680 shares, while Allan Gray …

Adicet Bio: A Cheap Gamma Delta T-Cell Play (NASDAQ:ACET)

Adicet Bio presents a differentiated allogeneic gamma delta CAR-T platform targeting autoimmune diseases, trading below cash value with a pivotal readout for prula-cel in lupus nephritis imminent in Q3 2026. Early data showed a 50% complete renal response and a clean safety profile. The …